Jingyi Qian1,2, Michael P Walkup3, Shyh-Huei Chen3, Peter H Brubaker4, Dale S Bond5, Phyllis A Richey6, John M Jakicic7, Kun Hu8,2, Frank A J L Scheer8,2, Roeland J W Middelbeek9. 1. Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, MA jqian@bwh.harvard.edu roeland.middelbeek@joslin.harvard.edu. 2. Division of Sleep Medicine, Department of Medicine, Harvard Medical School, Boston, MA. 3. Wake Forest School of Medicine, Winston-Salem, NC. 4. Wake Forest University Health & Exercise Science, Winston-Salem, NC. 5. The Miriam Hospital/Brown Alpert Medical School, Providence, RI. 6. Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN. 7. Healthy Lifestyle Institute, University of Pittsburgh, Pittsburgh, PA. 8. Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, MA. 9. Joslin Diabetes Center, Harvard Medical School, Boston, MA jqian@bwh.harvard.edu roeland.middelbeek@joslin.harvard.edu.
Abstract
OBJECTIVE: Moderate- to vigorous-intensity physical activity (MVPA) improves cardiovascular health. Few studies have examined MVPA timing. We examined the associations of timing of bout-related MVPA with cardiorespiratory fitness and cardiovascular risk in adults with type 2 diabetes. RESEARCH DESIGN AND METHODS: Baseline 7-day hip-worn accelerometry data from Look AHEAD participants (n = 2,153, 57% women) were analyzed to identify bout-related MVPA (≥3 METs/min for ≥10 min). Cardiorespiratory fitness was assessed by maximal graded exercise test. Participants were categorized into six groups on the basis of the time of day with the majority of bout-related MVPA (METs × min): ≥50% of bout-related MVPA during the same time window (morning, midday, afternoon, or evening), <50% of bout-related MVPA in any time category (mixed; the reference group), and ≤1 day with bout-related MVPA per week (inactive). RESULTS: Cardiorespiratory fitness was highly associated with timing of bout-related MVPA (P = 0.0005), independent of weekly bout-related MVPA volume and intensity. Importantly, this association varied by sex (P = 0.02). In men, the midday group had the lowest fitness (β = -0.46 [95% CI -0.87, -0.06]), while the mixed group in women was the least fit. Framingham risk score (FRS) was associated with timing of bout-related MVPA (P = 0.02), which also differed by sex (P = 0.0007). The male morning group had the highest 4-year FRS (2.18% [0.70, 3.65]), but no association was observed in women. CONCLUSIONS: Timing of bout-related MVPA is associated with cardiorespiratory fitness and cardiovascular risk in men with type 2 diabetes, independent of bout-related MVPA volume and intensity. Prospective studies are needed to determine the impacts of MVPA timing on cardiovascular health.
OBJECTIVE: Moderate- to vigorous-intensity physical activity (MVPA) improves cardiovascular health. Few studies have examined MVPA timing. We examined the associations of timing of bout-related MVPA with cardiorespiratory fitness and cardiovascular risk in adults with type 2 diabetes. RESEARCH DESIGN AND METHODS: Baseline 7-day hip-worn accelerometry data from Look AHEAD participants (n = 2,153, 57% women) were analyzed to identify bout-related MVPA (≥3 METs/min for ≥10 min). Cardiorespiratory fitness was assessed by maximal graded exercise test. Participants were categorized into six groups on the basis of the time of day with the majority of bout-related MVPA (METs × min): ≥50% of bout-related MVPA during the same time window (morning, midday, afternoon, or evening), <50% of bout-related MVPA in any time category (mixed; the reference group), and ≤1 day with bout-related MVPA per week (inactive). RESULTS: Cardiorespiratory fitness was highly associated with timing of bout-related MVPA (P = 0.0005), independent of weekly bout-related MVPA volume and intensity. Importantly, this association varied by sex (P = 0.02). In men, the midday group had the lowest fitness (β = -0.46 [95% CI -0.87, -0.06]), while the mixed group in women was the least fit. Framingham risk score (FRS) was associated with timing of bout-related MVPA (P = 0.02), which also differed by sex (P = 0.0007). The male morning group had the highest 4-year FRS (2.18% [0.70, 3.65]), but no association was observed in women. CONCLUSIONS: Timing of bout-related MVPA is associated with cardiorespiratory fitness and cardiovascular risk in men with type 2 diabetes, independent of bout-related MVPA volume and intensity. Prospective studies are needed to determine the impacts of MVPA timing on cardiovascular health.
Authors: Sean W Cain; Christopher F Dennison; Jamie M Zeitzer; Aaron M Guzik; Sat Bir S Khalsa; Nayantara Santhi; Martin W Schoen; Charles A Czeisler; Jeanne F Duffy Journal: J Biol Rhythms Date: 2010-08 Impact factor: 3.182
Authors: Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski Journal: N Engl J Med Date: 2013-06-24 Impact factor: 91.245
Authors: Andrea Di Blasio; Patrizio Ripari; Ines Bucci; Francesco Di Donato; Pascal Izzicupo; Emanuele D'Angelo; Barbara Di Nenno; Mariagrazia Taglieri; Giorgio Napolitano Journal: Menopause Date: 2012-01 Impact factor: 2.953
Authors: Leah M Schumacher; J Graham Thomas; Hollie A Raynor; Ryan E Rhodes; Kevin C O'Leary; Rena R Wing; Dale S Bond Journal: Obesity (Silver Spring) Date: 2019-07-03 Impact factor: 5.002
Authors: Xavier Pi-Sunyer; George Blackburn; Frederick L Brancati; George A Bray; Renee Bright; Jeanne M Clark; Jeffrey M Curtis; Mark A Espeland; John P Foreyt; Kathryn Graves; Steven M Haffner; Barbara Harrison; James O Hill; Edward S Horton; John Jakicic; Robert W Jeffery; Karen C Johnson; Steven Kahn; David E Kelley; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Brenda Montgomery; David M Nathan; Jennifer Patricio; Anne Peters; J Bruce Redmon; Rebecca S Reeves; Donna H Ryan; Monika Safford; Brent Van Dorsten; Thomas A Wadden; Lynne Wagenknecht; Jacqueline Wesche-Thobaben; Rena R Wing; Susan Z Yanovski Journal: Diabetes Care Date: 2007-03-15 Impact factor: 19.112
Authors: Sarah L Chellappa; Nina Vujovic; Jonathan S Williams; Frank A J L Scheer Journal: Trends Endocrinol Metab Date: 2019-08-16 Impact factor: 10.586
Authors: Mary O Whipple; Ana J Pinto; Layla A Abushamat; Audrey Bergouignan; Kristina Chapman; Amy G Huebschmann; Kevin S Masters; Kristen J Nadeau; Rebecca L Scalzo; Irene E Schauer; Deirdre Rafferty; Jane E B Reusch; Judith G Regensteiner Journal: Diabetes Care Date: 2022-09-01 Impact factor: 17.152
Authors: Mary-Margaret E Remchak; Kelsey L Piersol; Sabha Bhatti; Andrea M Spaeth; Jennifer F Buckman; Steven K Malin Journal: Nutrients Date: 2021-05-18 Impact factor: 5.717